Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of T Cell Specific Surface Glycoprotein CD28 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of T Cell Specific Surface Glycoprotein CD28market, defines the market attractiveness level of T Cell Specific Surface Glycoprotein CD28 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of T Cell Specific Surface Glycoprotein CD28 industry, describes the types of T Cell Specific Surface Glycoprotein CD28 market, the applications of major players and the market size, and deeply analyzes the current situation of the global T Cell Specific Surface Glycoprotein CD28 market and the development prospects and opportunities of T Cell Specific Surface Glycoprotein CD28 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global T Cell Specific Surface Glycoprotein CD28 market in Chapter 13.
By Player:
OSE Immunotherapeutics
Xencor
Bristol-Myers Squibb Co
Atox Bio Ltd
Five Prime Therapeutics Inc
TheraMAB LLC
Acro Bio Systems
Johnson & Johnson
R&D Systems
By Type:
FPT-155
FR-104
Lulizumab Pegol
Others
By End-User:
Plaque Psoriasis
Solid Tumor
Acute Renal Failure(ARF)
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 T Cell Specific Surface Glycoprotein CD28 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 T Cell Specific Surface Glycoprotein CD28 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 T Cell Specific Surface Glycoprotein CD28 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 T Cell Specific Surface Glycoprotein CD28 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise T Cell Specific Surface Glycoprotein CD28 Market Analysis and Outlook to 2022
-
7.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption (2017-2022)
-
7.2 United States T Cell Specific Surface Glycoprotein CD28 Consumption (2017-2022)
-
7.3 Europe T Cell Specific Surface Glycoprotein CD28 Consumption (2017-2022)
-
7.4 China T Cell Specific Surface Glycoprotein CD28 Consumption (2017-2022)
-
7.5 Japan T Cell Specific Surface Glycoprotein CD28 Consumption (2017-2022)
-
7.6 India T Cell Specific Surface Glycoprotein CD28 Consumption (2017-2022)
-
7.7 South Korea T Cell Specific Surface Glycoprotein CD28 Consumption (2017-2022)
8 Region and Country-wise T Cell Specific Surface Glycoprotein CD28 Market Analysis and Outlook to 2028
-
8.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption Forecast (2022-2028)
-
8.2 United States T Cell Specific Surface Glycoprotein CD28 Consumption Forecast (2022-2028)
-
8.3 Europe T Cell Specific Surface Glycoprotein CD28 Consumption Forecast (2022-2028)
-
8.4 China T Cell Specific Surface Glycoprotein CD28 Consumption Forecast (2022-2028)
-
8.5 Japan T Cell Specific Surface Glycoprotein CD28 Consumption Forecast (2022-2028)
-
8.6 India T Cell Specific Surface Glycoprotein CD28 Consumption Forecast (2022-2028)
-
8.7 South Korea T Cell Specific Surface Glycoprotein CD28 Consumption Forecast (2022-2028)
9 Global T Cell Specific Surface Glycoprotein CD28 Market Outlook by Types and Applications to 2022
-
9.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global FPT-155 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global FR-104 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lulizumab Pegol Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global T Cell Specific Surface Glycoprotein CD28 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Plaque Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Acute Renal Failure(ARF) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global T Cell Specific Surface Glycoprotein CD28 Market Outlook by Types and Applications to 2028
-
10.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global FPT-155 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global FR-104 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lulizumab Pegol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global T Cell Specific Surface Glycoprotein CD28 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Plaque Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Acute Renal Failure(ARF) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global T Cell Specific Surface Glycoprotein CD28 Import and Export Analysis (Top 5 Countries)
-
11.1 Global T Cell Specific Surface Glycoprotein CD28 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global T Cell Specific Surface Glycoprotein CD28 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 T Cell Specific Surface Glycoprotein CD28 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global T Cell Specific Surface Glycoprotein CD28 Market Competitive Analysis
-
14.1 OSE Immunotherapeutics
-
14.1.1 OSE Immunotherapeutics Company Details
-
14.1.2 OSE Immunotherapeutics T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 OSE Immunotherapeutics T Cell Specific Surface Glycoprotein CD28 Product and Service
-
14.2 Xencor
-
14.2.1 Xencor Company Details
-
14.2.2 Xencor T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Xencor T Cell Specific Surface Glycoprotein CD28 Product and Service
-
14.3 Bristol-Myers Squibb Co
-
14.3.1 Bristol-Myers Squibb Co Company Details
-
14.3.2 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product and Service
-
14.4 Atox Bio Ltd
-
14.4.1 Atox Bio Ltd Company Details
-
14.4.2 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product and Service
-
14.5 Five Prime Therapeutics Inc
-
14.5.1 Five Prime Therapeutics Inc Company Details
-
14.5.2 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product and Service
-
14.6 TheraMAB LLC
-
14.6.1 TheraMAB LLC Company Details
-
14.6.2 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product and Service
-
14.7 Acro Bio Systems
-
14.7.1 Acro Bio Systems Company Details
-
14.7.2 Acro Bio Systems T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Acro Bio Systems T Cell Specific Surface Glycoprotein CD28 Product and Service
-
14.8 Johnson & Johnson
-
14.8.1 Johnson & Johnson Company Details
-
14.8.2 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product and Service
-
14.9 R&D Systems
-
14.9.1 R&D Systems Company Details
-
14.9.2 R&D Systems T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 R&D Systems T Cell Specific Surface Glycoprotein CD28 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of T Cell Specific Surface Glycoprotein CD28
-
Figure T Cell Specific Surface Glycoprotein CD28 Picture
-
Table Global T Cell Specific Surface Glycoprotein CD28 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Consumption by Country (2017-2022)
-
Figure United States T Cell Specific Surface Glycoprotein CD28 Consumption and Growth Rate (2017-2022)
-
Table Europe T Cell Specific Surface Glycoprotein CD28 Consumption and Growth Rate (2017-2022)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Consumption and Growth Rate (2017-2022)
-
Figure Japan T Cell Specific Surface Glycoprotein CD28 Consumption and Growth Rate (2017-2022)
-
Figure India T Cell Specific Surface Glycoprotein CD28 Consumption and Growth Rate (2017-2022)
-
Figure South Korea T Cell Specific Surface Glycoprotein CD28 Consumption and Growth Rate (2017-2022)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Consumption Forecast by Country (2022-2028)
-
Figure United States T Cell Specific Surface Glycoprotein CD28 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe T Cell Specific Surface Glycoprotein CD28 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan T Cell Specific Surface Glycoprotein CD28 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India T Cell Specific Surface Glycoprotein CD28 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea T Cell Specific Surface Glycoprotein CD28 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FPT-155 Consumption and Growth Rate (2017-2022)
-
Figure Global FR-104 Consumption and Growth Rate (2017-2022)
-
Figure Global Lulizumab Pegol Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Plaque Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Renal Failure(ARF) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global FPT-155 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FR-104 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lulizumab Pegol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plaque Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Renal Failure(ARF) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Export by Region (Top 5 Countries) (2017-2028)
-
Table OSE Immunotherapeutics (Foundation Year, Company Profile and etc.)
-
Table OSE Immunotherapeutics T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table OSE Immunotherapeutics T Cell Specific Surface Glycoprotein CD28 Product and Service
-
Table Xencor (Foundation Year, Company Profile and etc.)
-
Table Xencor T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xencor T Cell Specific Surface Glycoprotein CD28 Product and Service
-
Table Bristol-Myers Squibb Co (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product and Service
-
Table Atox Bio Ltd (Foundation Year, Company Profile and etc.)
-
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product and Service
-
Table Five Prime Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product and Service
-
Table TheraMAB LLC (Foundation Year, Company Profile and etc.)
-
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product and Service
-
Table Acro Bio Systems (Foundation Year, Company Profile and etc.)
-
Table Acro Bio Systems T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acro Bio Systems T Cell Specific Surface Glycoprotein CD28 Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product and Service
-
Table R&D Systems (Foundation Year, Company Profile and etc.)
-
Table R&D Systems T Cell Specific Surface Glycoprotein CD28 Sales, Price, Value and Gross Profit (2017-2022)
-
Table R&D Systems T Cell Specific Surface Glycoprotein CD28 Product and Service
-
